| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 318,555 | 283,498 | 222,859 | | Cost of Revenue | 244,103 | 187,123 | 148,753 | | | Gross Profit | 74,452 | 96,375 | 74,106 | | | Operating Expenses | | Research Development | 54,043 | 38,324 | 35,615 | | Selling General and Administrative | 63,483 | 48,291 | 40,231 | | Non Recurring | 83,503 | 502 | 311 | | Others | 5,540 |
-
|
-
| | | | Total Operating Expenses | 206,569 |
-
|
-
| | | | Operating Income or Loss | (132,117) | 9,258 | (2,051) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,561 | 7,790 | 2,747 | | Earnings Before Interest And Taxes | (129,556) | 17,048 | 696 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (129,556) | 17,048 | 696 | | Income Tax Expense | 16 |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (129,572) | 17,048 | 696 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (129,572) | 17,048 | 696 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($129,572) | $17,048 | $696 |
|
1.00% Nasdaq 0.00%
Income Statement
